Loomis, Sayles & Company’s Qiagen QGEN Stock Holding History

Loomis, Sayles & Company’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-250	Closed	-$12K	–	911
2023 Q4	$12K	Buy	+250	New	+$10.6K	﹤0.01%	749
2022 Q3	–	Sell	-46	Closed	-$2K	–	1028
2022 Q2	$2K	Hold	46	–	–	﹤0.01%	874
2022 Q1	$2K	Buy	+46	New	+$2.37K	﹤0.01%	964
2017 Q4	–	Sell	-720	Closed	-$24K	–	922
2017 Q3	$24K	Buy	720 +35	+5%	+$1.21K	﹤0.01%	740
2017 Q2	$24K	Buy	+685	New	+$23.1K	﹤0.01%	744

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Loomis, Sayles & Company's QGEN Position: Q1 2024 in Review

Loomis, Sayles & Company sold out of Qiagen (QGEN) in Q1 2024, closing a stake of 250 shares — an estimated $12K sold.

Loomis, Sayles & Company first reported a position in QGEN in Q2 2017 and held it in 5 quarters. The position peaked at $24K in Q3 2017. 282 funds tracked by Wall St. Rank hold QGEN as of Q1 2024.

Loomis, Sayles & Company reported no remaining Qiagen position as of Q1 2024 after selling out during the quarter.
Loomis, Sayles & Company sold 250 Qiagen shares in Q1 2024, an estimated $12K.
Loomis, Sayles & Company first reported a position in Qiagen in Q2 2017 and held it in 5 quarters.
Loomis, Sayles & Company's Qiagen position peaked at $24K in Q3 2017.
282 funds tracked by Wall St. Rank held Qiagen as of Q1 2024.

Based on Loomis, Sayles & Company's 13F filing for Q1 2024, filed 14 May 2024.